Randomised controlled trialindependent cross-checkabstract only checked I-FAST-04 standard review

16:8 fasting without calorie targets

Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial.

Overview

Lowe DA et al.. JAMA Intern Med 2020 · PMID 32986097 · DOI 10.1001/jamainternmed.2020.4153

No more weight loss than three meals a day, and slightly more muscle-related lean mass loss.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Effect of 16:8 TRE on weight and metabolic markers

How was the study done?

RCT, 12 weeks, app-based (TREAT)

How many people, animals or samples were studied?

116; Adults with BMI 27-43

What was actually found?

Null on weight.

How large was the observed effect?

-0.26 kg (n.s.)

What do the results mean in everyday life?

Timing alone does little.

What are the study's limitations?

Short; Self-reported adherence

What does it say about Elawady's specific claim?

Limits C-FAST-05; lean mass loss relevant to C-FAST-08.

Do the results apply to Germany and Europe?

US.

What can explicitly not be concluded from this study?

Long-term effects.

Scientific in-depth review

1. Full reference

Authors
Lowe DA et al.
Journal
JAMA Intern Med
Year
2020
Identifier
PMID 32986097 DOI 10.1001/jamainternmed.2020.4153
Verification
verified – PubMed efetch 2026-10-25 (this agent)
Retracted
no
Corrections

ErratumIn: JAMA Intern Med. 2020 Nov 1;180(11):1555. doi: 10.1001/jamainternmed.2020.6728.; ErratumIn: JAMA Intern Med. 2021 Jun 1;181(6):883. doi: 10.1001/jamainternmed.2020.8941.

Extent checked
abstract only
Conflicts of interest and funding

NIH and other funding; corrections issued (see verification).

2. Research question

Effect of 16:8 TRE on weight and metabolic markers

3. Study design and population

Study design
Randomised controlled trial – RCT, 12 weeks, app-based (TREAT)
Population

Adults with BMI 27-43

Country

USA

Period

12 weeks

Sample size

116

Inclusion and exclusion criteria

As described in the abstract; details not available in abstract.

4. Methods and endpoints

Exposure / intervention

16:8 time-restricted eating

Comparator

Three structured meals per day

Endpoints

Weight; secondary metabolic markers

Statistical methods

Mixed models

5. Actual results

Results

TRE -0.94 kg within group; between groups -0.26 kg (P=0.63); in-person cohort: appendicular lean mass index decreased more with TRE (-0.16 kg/m2); no other differences.

Absolute risks

not reported

Authors' conclusion

TRE alone is not more effective for weight loss than eating throughout the day.

6. Strengths

  • Randomised

7. Weaknesses

  • Short
  • Self-reported adherence

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Remote trial.

9. Assessment of the statistical interpretation

Null.

10. Relevance to the specific claim

Limits C-FAST-05; lean mass loss relevant to C-FAST-08.

11. Independent contrary findings

12. Transferability to Germany and Europe

US.

13. Overall methodological judgement

No benefit of TRE alone.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

None beyond those stated.

15. Linked fact checks